-+ 0.00%
-+ 0.00%
-+ 0.00%
Stock round-up (3) SanBio, Note SanBio announced the initiation of a clinical trial for its regenerative medicine. The company aims to develop treatments for spinal cord injuries. Note, a tech company, released a new version of its digital notebook app with enhanced features. The update includes improved handwriting recognition and cloud synchronization.
Share

Please log in to view news

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending